NeoPharm Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - NeoPharm Co Ltd

Watchlist Manager

Watchlist

Price: 22 950 KRW -0.86% Market Closed

Market Cap: ₩367.9B

N	NeoPharm Co Ltd KOSDAQ:092730	KR
	CS Group SA PAR:SX	FR
	Cicor Technologies Ltd SIX:CICN	CH

Profitability Summary

NeoPharm Co Ltd's profitability score is 67/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

66%

Strong 3Y Average Gross Margin

65%

Declining Gross Margin

69% > 66%

Healthy Operating Margin

22%

Sustainable 3Y Average Operating Margin

23%

Declining Operating Margin

26% > 22%

Healthy Net Margin

21%

Sustainable 3Y Average Net Margin

21%

Declining Net Margin

22% > 21%

Exceptional Free Cash Flow Margin

17%

Strong 3Y Average Free Cash Flow Margin

12%

Declining Free Cash Flow Margin

23% > 17%

Positive ROE

16%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

38%

Declining ROIC

46% > 39%

View All

Hide

Collapse

67 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.